EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Multi‐Omics Identifies S100A4 as a Translational Hub Linking Environmental Bis(2‐Ethylhexyl) Phthalate (DEHP) Exposure to Glioblastoma Risk

Shasha Tan iD, Zhou Li, Zhenjiang Du iD, Jinliang You iD, Lichun Qiao iD, Long Zhao iD, Binbin Yang iD, Xiaoping Tang iD, Sajjad Muhammad iD, Hongjun Liu iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/2385129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 23.02.2026. Verfasst von Shasha Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, Sichuan, China, hospital-nsmc.com.cn. Hauptthemen laut MEDLINE: Glioblastoma, S100 Calcium-Binding Protein A4, Diethylhexyl Phthalate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is a highly aggressive central nervous system malignancy with a dismal 5‐year survival rate of less than 5%, and poorly understood environmental factors complicate its treatment. One such factor is bis(2‐ethylhexyl) phthalate (DEHP, also known as di‐2‐ethylhexyl phthalate), a common plasticizer with documented neurotoxicity, yet its potential role in GBM pathogenesis remains elusive. In this study, we employed an integrative computational framework that combined network toxicology, single‐cell transcriptomics, proteome‐wide and metabolome‐wide Mendelian randomization (MR), and molecular dynamics (MD) simulations to systematically investigate the interplay between DEHP and GBM risk. Cross‐dataset targets were identified by mining toxicogenomic and disease databases, followed by the construction of a protein–protein interaction (PPI) network. This approach identified 76 overlapping targets between DEHP and GBM, which were refined to 24 hub genes through topological analysis. Notably, MR analyses revealed putative causal associations between higher genetically predicted plasma levels of three hub proteins—CD63, CTSS, and S100A4—and an increased risk of GBM, with S100A4 showing the strongest effect (odds ratio [OR] = 2.03, 95% confidence interval [CI] 1.15–3.58, p = 0.0149). This association was consistently validated across 11 independent cohorts, including TCGA, GTEx, and GEO datasets. Molecular docking and dynamics simulations identified S100A4 as the predominant binding target of DEHP, revealing a high‐affinity interaction that may stabilize a metastasis‐associated conformation. A two‐step MR mediation analysis further indicated that S100A4 partially influences GBM risk by altering plasma lipid metabolites, with erucic acid mediating ~17% of the total effect. In conclusion, our analysis provides converging computational and genetic epidemiological evidence for a novel DEHP–S100A4–lipid metabolic axis that may contribute to GBM development. This pathway conceptually bridges environmental toxicology and neuro‐oncology and highlights S100A4 and associated lipid disturbances as potential targets for preventive intervention. However, the proposed mechanistic links remain inferential, and definitive confirmation will require future in vitro and in vivo experiments to directly test the impact of DEHP on S100A4 expression, function, and downstream metabolic reprogramming in GBM models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaS100 Calcium-Binding Protein A4Diethylhexyl PhthalateHumansMolecular Dynamics SimulationProtein Interaction MapsMultiomics

Stichwörter der Autor:innen

DEHPMendelian randomizationS100A4glioblastomalipid metabolic reprogrammingmolecular dynamicsmulti-omics

Substanzen

S100 Calcium-Binding Protein A4Diethylhexyl PhthalateS100A4 protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, Sichuan, China, hospital-nsmc.com.cn.
  • Department of Neurosurgery, Beijing Anzhen Nanchong Hospital of Capital Medical University and Nanchong Central Hospital, Nanchong, 637000, Sichuan, China.
  • Department of Neurosurgery, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, 40225, Germany, uni-duesseldorf.de.
  • School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China, xjtu.edu.cn.

ORCID-Profile: Shasha Tan, Zhenjiang Du, Jinliang You, Lichun Qiao, Long Zhao, Binbin Yang, Xiaoping Tang, Sajjad Muhammad, Hongjun Liu

Zitieren

APA

Tan, S., Li, Z., Du, Z., You, J., Qiao, L., Zhao, L., Yang, B., Tang, X., Muhammad, S., & Liu, H. (2026). Integrative Multi‐Omics Identifies S100A4 as a Translational Hub Linking Environmental Bis(2‐Ethylhexyl) Phthalate (DEHP) Exposure to Glioblastoma Risk. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/2385129

Vancouver

Tan S, Li Z, Du Z, You J, Qiao L, Zhao L, et al. Integrative Multi‐Omics Identifies S100A4 as a Translational Hub Linking Environmental Bis(2‐Ethylhexyl) Phthalate (DEHP) Exposure to Glioblastoma Risk. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/2385129

BibTeX
@article{Tan2026,
  author = {Tan, Shasha and Li, Zhou and Du, Zhenjiang and You, Jinliang and Qiao, Lichun and Zhao, Long and Yang, Binbin and Tang, Xiaoping and Muhammad, Sajjad and Liu, Hongjun},
  title = {Integrative Multi‐Omics Identifies S100A4 as a Translational Hub Linking Environmental Bis(2‐Ethylhexyl) Phthalate (DEHP) Exposure to Glioblastoma Risk},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/2385129}
}
Kostenlos starten →